ask="2.30"
ask_size="900"
average_daily_volume="1997910"
bid="2.10"
bid_size="200"
book_value="4.54"
change="+0.00"
change_from_200_day_moving_average="-0.51"
change_from_50_day_moving_average="-0.06"
change_from_52_week_high="-1.69"
change_From_52_week_low="0.22"
change_in_percent="+0.00%"
close="2.15"
dividend_pay_date="6/13/2016"
dividend_per_share="0.00"
dividend_yield="6.41"
earnings_per_share="0.39"
ebitda="149.51M"
eps_estimate_current_year="0.18"
eps_estimate_next_quarter="0.05"
eps_estimate_next_year="0.41"
ex_dividend_date="6/2/2016"
float_shares="149095000"
high="2.20"
high_52_weeks="3.84"
last_trade_date="3/13/2017"
last_trade_price="2.15"
last_trade_size="76788"
last_trade_time="4:00pm"
low="2.15"
low_52_weeks="1.93"
market_capitalization="355.95M"
moving_average_200_day="2.66"
moving_average_50_day="2.21"
name="PDL BioPharma
Inc."
notes="N/A"
one_year_target_price="3.67"
open="2.15"
pe_ratio="5.54"
peg_ratio="0.85"
percent_change_from_200_day_moving_average="-19.18%"
percent_change_from_50_day_moving_average="-2.82%"
percent_change_from_52_week_high="-44.01%"
percent_change_from_52_week_low="+11.40%"
previous_close="2.15"
price_eps_estimate_current_year="11.94"
price_eps_Estimate_next_year="5.24"
price_per_book="0.47"
price_per_sales="1.80"
revenue="197.70M"
shares_outstanding="165558000"
short_ratio="7.12"
stock_exchange="NMS"
symbol="PDLI"
volume="1419409"
weeks_range_52="1.93 - 3.84"
